ASCO GI: Agent Targets IGF Receptor in Pancreatic Cancer (CME/CE) (source: medpagetoday.com) no comments
Posted at 10:52 pm in Object
ORLANDO (MedPage Today) — A majority of patients with advanced pancreatic cancer had objective responses or stable disease when treated with an inhibitor of insulin-like growth factor receptor, data from a small clinical trial showed. (source: medpagetoday.com) - RSS widgets and RSS feeds on Feedzilla.com
Read the original:
ASCO GI: Agent Targets IGF Receptor in Pancreatic Cancer (CME/CE) (source: medpagetoday.com)